Salbutamol sulfate

硫酸沙丁胺醇

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameSalbutamol sulfate
Drug Alias Name硫酸沙丁胶醇AlbuterolSalbutamolum沙丁胺醇硫酸盐Albuterol sulfate +[38] 
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsPost Operative Pulmonary Air LeakExercise-induced bronchoconstrictionBronchoconstriction +[28] 
Global Approved IndicationsEmphysemaAirway ObstructionBronchial Spasm +[6] 
Approved Indications in ChinaAsthma
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1968/11/29
Country/TerritoryCanadaPanamaUnited States +[25] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesPolarean IncGlaxosmithkine Australia Pty LtdTongji University +[9] 
Inactive CompaniesUniversity Of California San FranciscoPharmobedient Consulting LLCConcentrx Pharmaceuticals Inc +[22] 
Active IndicationsPost Operative Pulmonary Air LeakEmphysemaObesity +[13] 
Inactive IndicationsExercise-induced bronchoconstrictionBronchoconstrictionOrganophosphate Poisoning +[15] 

Other Information

ATC CodeR03AC02R03CC02
Related LinksWikipediaDrugBankKEGG